| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |
| mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.3 |